Reference Codes
Please select the appropriate billing code when filing all claims. Billing codes should be based on diagnosis and the services provided. The codes most commonly associated with the billing and reimbursement of Cathflo are given below. We cannot guarantee that use of the following billing codes will result in reimbursement.1
| ICD-9 Codes | |
| 996.74 | Other complications of other vascular device, implant, and graft |
| CPT®1 Codes | |
| 36593 | Declotting by thrombolytic agent of implanted vascular access device or catheter |
| NDC | |
| 50242-041-64 | National Drug Code for Cathflo powder for injection |
| HCPCS | |
| J2997 | Alteplase recombinant (Cathflo) 1 mg dosage IV |
Indication
Cathflo Activase (Alteplase) is indicated for the restoration of function to central venous access devices (CVADs) as assessed by the ability to withdraw blood.
Safety Information
Cathflo Activase should not be administered to patients with known hypersensitivity to Alteplase or any component of the formulation.
In clinical trials, the most serious adverse events reported after treatment were sepsis, gastrointestinal bleeding, and venous thrombosis.
Please click here for full prescribing information.
For further information regarding drug pricing, please refer to the Medicare Web site.
If you do not have Adobe Reader installed or wish to update your existing reader, please download the free basic reader.All Current Procedural Terminology (CPT) five-digit numeric codes, descriptions, numeric modifiers, instructions, guidelines, and other materials included in this handout are copyright 2010 American Medical Association. All rights reserved.
